Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:I-302-I-307
doi: 10.1161/CIRCULATIONAHA.105.001339
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salzberg, S. P.
Right arrow Articles by Adams, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salzberg, S. P.
Right arrow Articles by Adams, D. H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Diabetes

(Circulation. 2006;114:I-302 – I-307.)
© 2006 American Heart Association, Inc.


Myocardial Protection and Vascular Biology

Increased Neointimal Formation After Surgical Vein Grafting in a Murine Model of Type 2 Diabetes

Sacha P. Salzberg, MD; Farzan Filsoufi, MD; Anelechi Anyanwu, MD; Kai von Harbou, MD; Eva Karlof, MD; Alain Carpentier, MD, PhD; Hayes M. Dansky, MD; David H. Adams, MD

From the Department of Cardiothoracic Surgery (S.P.S., F.F., A.A., K.v.H., E.K., A.C., D.H.A.), Mount Sinai Medical Center, New York, NY; Division of Cardiology (H.M.D.), Columbia University, New York, NY.

Correspondence to Sacha P. Salzberg, Department of Cardiothoracic Surgery, Mount Sinai Medical Center, 1190 Fifth Ave, Box 1028, NY, NY 10029. E-mail sacha.salzberg{at}gmail.com

Background— Diabetes is an independent risk factor for the development of neointimal hyperplasia and subsequent vein graft failure after coronary or peripheral artery bypass grafting. We evaluate a new mouse model of surgical vein grafting to investigate the mechanisms of neointimal formation in the setting of type 2 diabetes.

Methods and Results— Surgical vein grafts were created by inserting vein segments from age-matched C57BL/KsJ wild-type mice into the infra-renal aorta of leprdb/db diabetic and C57BL/KsJ wild-type mice. Mice were euthanized &4 weeks later, and vein grafts were analyzed using morphometric and immunohistochemical techniques. A significant increase in neointimal formation was noted in leprdb/db mice (139±64 versus 109±62 mm2; P=0.008) after 4 weeks. This difference was mainly secondary to an increase in collagen formation within the lesion in the vein grafts from leprdb/db mice (0.53±0.4 versus 0.44±0.05; P<0.001), whereas only slight increases (P=not significant) in alpha actin-stained smooth muscle cells were noted in the leprdb/db mice.

Conclusion— We established a new physiologically relevant model of surgical vein grafting in mice. In this report, type 2 diabetes was associated with significant increase in extracellular matrix deposition in addition to increased smooth muscle cell deposition. This new model may allow mechanistic studies of cellular and molecular pathways of increased neointimal formation in the setting of diabetes.


Key Words: coronary artery disease • diabetes • mouse • neointima • surgery